News

LivaNova PLC and MicroPort Scientific Corporation announced that the companies have entered into a binding Letter of Intent (LOI) for the sale of LivaNova’s Cardiac Rhythm Management (CRM) Business Franchise to MicroPort for $190 million in...

Zenicor Medical Systems announces that the pilot project that has been carried out in northern Finland during the first half of 2017 has shown positive results. The improved care pathway for atrial fibrillation and arrhythmias tested in the...

A study of two medications that can reduce risk of ischemic stroke in people with atrial fibrillation showed that outcomes in typical patients with atrial fibrillation align well with those seen in clinical trials. The findings were published...

EBR Systems, Inc., developer of the world’s first and only wireless cardiac pacing system for heart failure, has raised $50 million to conduct the global SOLVE-CRT study. The financing was led by Australian private equity firms M.H. Carnegie...

Cardiac Insight, Inc., a U.S. developer of wearable medical devices and diagnostic software, announced that the company has secured its first cardiology customers for its wearable ECG sensor device, Cardea SOLO, in Texas and several other...

Updated guidelines issued by the American Heart Association (AHA), the American College of Cardiology (ACC) and the Heart Rhythm Society (HRS) now formally recommend the use of a subcutaneous implantable cardioverter-defibrillator (S-ICD) for...

Aziyo Biologics, Inc., a fully integrated regenerative medicine company, announced the launch of a new CanGaroo Bio Envelope specifically for use with subcutaneous implantable cardioverter-defibrillators (S-ICDs). This is the only cardiac...

Cardiome Pharma Corp. announced the expansion of its geographic presence for Brinavess (vernakalant hydrochloride, IV) into the two new key territories of South Africa and Pakistan.  Following the recent receipt of authorization from...

Boston Scientific announced final five-year outcomes data from the PREVAIL study of the WATCHMAN™ Left Atrial Appendage Closure (LAAC) Device during a late-breaking clinical trial session at the 29th Transcatheter Cardiovascular Therapeutics...

Imricor and MiRTLE Medical announce a joint development agreement to fully integrate MiRTLE’s MR compatible 12-lead ECG system with Imricor’s Advantage-MR™ EP Recorder/Stimulator System. This integration, along with Imricor’s MR compatible...